ICOS and T-cell non-Hodgkin lymphoma: In T-cell lymphoma carrying the NPM-ALK fusion protein (ALK-TCL), miR-219 was found to target cell-stimulatory receptor ICOS (inducible T-cell co-stimulator or CD278) which was known to promote the proliferation of T-cells [28].